Journal of ISSN: 2376-0060JLPRR

Lung, Pulmonary & Respiratory Research
Editorial
Volume 2 Issue 6 - 2015
Asbestosis
Attapon Cheepsattayakorn1,2,3* and Ruangrong Cheepsattayakorn4
1Editor-in-Chief, Journal of Lung Pulmonary and Respiratory Research, USA
210th Zonal Tuberculosis and Chest Disease Center, Thailand
3Department of Disease Control, Ministry of Public Health, Thailand
4Department of Pathology, Chiang Mai University, Thailand
Received: December 11, 2015 | Published: December 14, 2015
*Corresponding author: Attapon Cheepsattayakorn, 10th Zonal Tuberculosis and Chest Disease Center, 143 Sridornchai Road Changklan Muang Chiang Mai 50100 Thailand, Tel : 66 53 140767; 66 53 276364; Fax : 66 53 140773; 66 53 273590; Email : ;
Citation: Cheepsattayakorn A, Cheepsattayakorn R (2015) Asbestosis. J Lung Pulm Respir Res 2(6): 00064. DOI: 10.15406/jlprr.2015.02.00064

Editorial

Asbestosis, a chronic lung disease that develops from inhalation of asbestos fibers, which contribute to lung tissue scarring. Asbestos fibers, a natural mineral product are heat-resistant fibrous silicate. Chrysotile is by far the most common type of asbestos fibers produced in the world and commercially virtual used in the United States. The symptoms usually don’t present until many years after continued exposure. Prolonged exposure can cause shortness of breath. Its production and use increased significantly between 1877 and 1967. Several previous studies indicated asbestos as a predisposing factor for malignant mesothelioma and bronchogenic carcinoma. Many cases come from work place exposure to asbestos before the United States federal laws regulating it were enacted in the mid-1970s. Today, its handling is strictly regulated. If we follow the employer’s safety procedures, acquiring asbestosis is extremely unlikely. According to the American Lung Association (ALA), more than 3, 000 deadly cases of it found in the United States from 1999 to 2004. Only relieving the patient’s symptoms is the focusing treatment.

© 2014-2016 MedCrave Group, All rights reserved. No part of this content may be reproduced or transmitted in any form or by any means as per the standard guidelines of fair use.
Creative Commons License Open Access by MedCrave Group is licensed under a Creative Commons Attribution 4.0 International License.
Based on a work at http://medcraveonline.com
Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version | Opera |Privacy Policy